Investigation of a novel prognostic marker in head and neck squamous cell carcinoma
| Project/Area Number |
23791875
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Otorhinolaryngology
|
|---|
| Research Institution | Teikyo University (2012)
Chiba University (2011) |
|---|
Principal Investigator |
KATADA Koji 帝京大学, 医学部, 助教 (60596112)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | 頭頸部癌 / プロテオミクス / 予後マーカー |
|---|
| Research Abstract |
We identified plectin as a promising prognostic biomarker in head and neck squamous cell carcinoma (HNSCC) using proteomic technics and functional studies implied that a decreased expression of plectin suppresses the proliferation,migration and invasion of HNSCC cells. Furthermore, the survival rate of patients with high plectin was significantly lower than that of patients with low E-cadherin levels, which is known to correlate with the poor prognosis of HNSCC.
|
Report
(3 results)
Research Products
(4 results)
